128 related articles for article (PubMed ID: 33386712)
1. Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma.
Kurtz DM
Haematologica; 2021 Jan; 106(1):5-6. PubMed ID: 33386712
[No Abstract] [Full Text] [Related]
2. Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma.
Bessi L; Viailly PJ; Bohers E; Ruminy P; Maingonnat C; Bertrand P; Vasseur N; Beaussire L; Cornic M; Etancelin P; Camus V; Picquenot JM; Tilly H; Stamatoullas A; Jardin F
Leuk Lymphoma; 2019 Feb; 60(2):498-502. PubMed ID: 30068243
[No Abstract] [Full Text] [Related]
3. Clinical applications of circulating tumor DNA in Hodgkin lymphoma.
Heger JM; Ferdinandus J; Mattlener J; Borchmann S
Semin Hematol; 2023 Jul; 60(3):157-163. PubMed ID: 37422345
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
Shi Y; Su H; Song Y; Jiang W; Sun X; Qian W; Zhang W; Gao Y; Jin Z; Zhou J; Jin C; Zou L; Qiu L; Li W; Yang J; Hou M; Xiong Y; Zhou H; Du X; Wang X; Peng B
EBioMedicine; 2020 Apr; 54():102731. PubMed ID: 32304999
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V; Bruscaggin A; Cuccaro A; Martini M; Di Trani M; Forestieri G; Manzoni M; Condoluci A; Arribas A; Terzi-Di-Bergamo L; Locatelli SL; Cupelli E; Ceriani L; Moccia AA; Stathis A; Nassi L; Deambrogi C; Diop F; Guidetti F; Cocomazzi A; Annunziata S; Rufini V; Giordano A; Neri A; Boldorini R; Gerber B; Bertoni F; Ghielmini M; Stüssi G; Santoro A; Cavalli F; Zucca E; Larocca LM; Gaidano G; Hohaus S; Carlo-Stella C; Rossi D
Blood; 2018 May; 131(22):2413-2425. PubMed ID: 29449275
[TBL] [Abstract][Full Text] [Related]
6. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.
Desch AK; Hartung K; Botzen A; Brobeil A; Rummel M; Kurch L; Georgi T; Jox T; Bielack S; Burdach S; Classen CF; Claviez A; Debatin KM; Ebinger M; Eggert A; Faber J; Flotho C; Frühwald M; Graf N; Jorch N; Kontny U; Kramm C; Kulozik A; Kühr J; Sykora KW; Metzler M; Müller HL; Nathrath M; Nüßlein T; Paulussen M; Pekrun A; Reinhardt D; Reinhard H; Rössig C; Sauerbrey A; Schlegel PG; Schneider DT; Scheurlen W; Schweigerer L; Simon T; Suttorp M; Vorwerk P; Schmitz R; Kluge R; Mauz-Körholz C; Körholz D; Gattenlöhner S; Bräuninger A
Leukemia; 2020 Jan; 34(1):151-166. PubMed ID: 31431735
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
8. Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin's lymphoma.
Mangano C; Ferrarini A; Forcato C; Garonzi M; Tononi P; Lanzellotto R; Raspadori A; Bolognesi C; Buson G; Medoro G; Hummel M; Fontana F; Manaresi N
Blood Cancer J; 2019 Nov; 9(12):92. PubMed ID: 31754095
[No Abstract] [Full Text] [Related]
9. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
Wu FT; Lu L; Xu W; Li JY
Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
[TBL] [Abstract][Full Text] [Related]
10. Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma.
Mata E; Fernández S; Astudillo A; Fernández R; García-Cosío M; Sánchez-Beato M; Provencio M; Estévez M; Montalbán C; Piris MA; García JF
Blood Cancer J; 2019 Mar; 9(3):34. PubMed ID: 30858359
[No Abstract] [Full Text] [Related]
11. Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.
Watanabe J; Natsumeda M; Kanemaru Y; Okada M; Oishi M; Kakita A; Fujii Y
Leuk Lymphoma; 2019 Dec; 60(14):3587-3589. PubMed ID: 31305194
[No Abstract] [Full Text] [Related]
12. Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease.
Tiemann M; Samoilova V; Atiakshin D; Buchwalow I
BMC Res Notes; 2020 Mar; 13(1):139. PubMed ID: 32143684
[TBL] [Abstract][Full Text] [Related]
13. An update on disease biomarkers for Hodgkin lymphoma.
Cirillo M; Borchmann S
Expert Rev Hematol; 2020 May; 13(5):481-488. PubMed ID: 32193957
[No Abstract] [Full Text] [Related]
14. Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin Lymphoma.
Melani C; Roschewski M
Oncology (Williston Park); 2016 Aug; 30(8):731-8, 744. PubMed ID: 27539624
[TBL] [Abstract][Full Text] [Related]
15. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Biomarkers for Hodgkin Lymphoma.
Staege MS; Kewitz S; Bernig T; Kühnöl C; Mauz-Körholz C
Pediatr Hematol Oncol; 2015; 32(7):433-54. PubMed ID: 26380871
[TBL] [Abstract][Full Text] [Related]
17. Circulating-tumor DNA as an early detection and diagnostic tool.
Butler TM; Spellman PT; Gray J
Curr Opin Genet Dev; 2017 Feb; 42():14-21. PubMed ID: 28126649
[TBL] [Abstract][Full Text] [Related]
18. [Clinical research of circulating tumor DNA: progress and prospect].
Jiang HQ; Guo W
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):165-171. PubMed ID: 32008280
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
[No Abstract] [Full Text] [Related]
20. Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma.
Heger JM; Borchmann S
Leuk Lymphoma; 2022 Apr; 63(4):768-770. PubMed ID: 35021930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
